Echo Pharmaceuticals

Echo Pharmaceuticals is a pioneering pharmaceutical company based in The Netherlands since 2006. The company specializes in the extraction, purification, and formulation of lipophilic active compounds, with a particular focus on cannabinoids. Echo Pharmaceuticals leverages its patented drug formulation knowledge to develop optimized formulations for clinical investigations, and conducts clinical trials. Their proprietary expertise lies in the extraction and purification of various active pharmaceutical ingredients (APIs) from plant materials, all performed under stringent laboratory conditions to ensure high-quality end products. The company's product range includes a variety of cannabinoid standards for analytical purposes and two cannabinoid APIs, all manufactured in adherence to cGMP guidelines. Echo Pharmaceuticals is well-recognized for supplying R&D organizations worldwide with its unique pharmaceutical offerings. With a compelling vision to enhance patients' quality of life through the development of innovative medicines, Echo Pharmaceuticals stands at the forefront of the Pharmaceutical industry.